PPTA's North America division is actively engaged in setting an advocacy and priority agenda for patient access. Staff monitors pending legislation, informs government representatives and works diligently to advance positions that protect the interests of patients who rely on life-saving, plasma protein therapies (PPTs). The Federal Affairs advocates with Members of Congress and Congressional staff on legislative issues related to PPTs, access to therapies and reimbursement. The Association also works in state capitals throughout the U.S. to ensure patient access to therapies, reimbursement and implementation of the Affordable Care Act (ACA).
In North America, PPTA advocates on behalf of patients not only at the state and federal level in the United States but also in Canada: